Oncology & Cancer

A 'leap forward' in risk management of rectal cancer

Rectal cancer, along with colon cancer, is the third-most common type of cancer in the United States, and treatment and surgery greatly affect the quality of life of patients. A multi-disciplinary team at Washington University ...

Oncology & Cancer

New clinical guideline on radiation therapy for rectal cancer

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance for physicians who use radiation therapy to treat patients with locally advanced rectal cancer. Recommendations outline indications ...

Oncology & Cancer

New drug combination passes safety test in pancreatic cancer

A new study has shown a novel peptide antagonist, given in combination with a PD-1 inhibitor, to be safe and well-tolerated in patients with advanced, refractory pancreatic and rectal cancer. The highest dose tested had a ...

Oncology & Cancer

Less chemotherapy may have more benefit in rectal cancer

Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx ...

page 1 from 10